Position in MRK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$517,341
+$37,866 QoQ
Shares Held
4,026
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#2,668
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Weaver Consulting Group holds $4,407,808 across 7 Drug Manufacturers - General names. MRK ranks #5 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,013 | $1,273,151 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,077 | $767,768 | |
| 3 | LLY |
ELI LILLY & Co
|
551 | $660,885 | |
| 4 | AMGN |
Amgen Inc
|
1,633 | $591,341 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
4,026 | $517,341 | |
| 6 | ABBV |
AbbVie Inc.
|
1,228 | $309,013 | |
| 7 | PFE |
Pfizer Inc
|
11,973 | $288,309 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $517,341 | 4,026 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $479,475 | 3,986 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $419,566 | 3,986 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $343,357 | 4,091 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $329,859 | 4,167 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $376,992 | 4,200 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $332,462 | 3,342 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $379,517 | 3,342 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $413,739 | 3,342 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $440,976 | 3,342 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $364,344 | 3,342 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $344,058 | 3,342 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $408,711 | 3,542 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $389,387 | 3,660 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $405,522 | 3,655 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $319,505 | 3,710 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $338,240 | 3,710 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $294,149 | 3,585 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $276,823 | 3,612 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $272,048 | 3,622 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $280,983 | 3,613 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $288,239 | 3,739 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $244,663 | 2,991 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $247,274 | 2,981 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $236,552 | 3,059 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $233,205 | 3,031 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||